HOSPITAL UNIVERSITARIO RUBER
Departamento
Princess Margaret Cancer Centre
Toronto, CanadáPublicaciones en colaboración con investigadores/as de Princess Margaret Cancer Centre (4)
2022
-
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer
New England Journal of Medicine, Vol. 387, Núm. 3, pp. 217-226
2021
-
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
npj Breast Cancer, Vol. 7, Núm. 1
2020
2019
-
Genomic alterations in breast cancer: Level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
Annals of Oncology, Vol. 30, Núm. 3, pp. 365-373